149
Views
6
CrossRef citations to date
0
Altmetric
Original

Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: Results of CALGB 59906

, , , , , , & show all
Pages 1511-1517 | Received 10 Nov 2005, Accepted 13 Jan 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mark Kirschbaum. (2009) Comeback for the camptothecins?. Leukemia & Lymphoma 50:12, pages 1914-1915.
Read now

Articles from other publishers (5)

Paulus A. F. Geerts, Nils ’t Hart, Otto Visser, Valentín Ortiz‐Maldonado & Martine E. D. Chamuleau. (2023) Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion . Clinical Case Reports 11:6.
Crossref
Kathryn M. Camacho, Sunny Kumar, Stefano Menegatti, Douglas R. Vogus, Aaron C. Anselmo & Samir Mitragotri. (2015) Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid. Journal of Controlled Release 210, pages 198-207.
Crossref
YaJuan Shao, Mei Guan, ShuChang Chen, Ning Jia & YuZhou Wang. (2014) Topotecan combined with Ifosfamide, Etoposide, and l-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma. Medical Oncology 32:1.
Crossref
Nancy L. Bartlett, Jeffrey L. Johnson, Nina Wagner-Johnston, Mark J. Ratain & Bruce A. Peterson. (2008) Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551. Cancer Chemotherapy and Pharmacology 63:5, pages 793-798.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.